This study is an extension of Dr. Bull’s other ongoing research (Assessing the Transition from Acute to Chronic Cancer Pain (AtTACC Pain) Study) by adding proteomics analyses to the AtTACC pain cohort, which will enhance the understanding of the biological underpinnings in the transition from acute to chronic cancer pain.
(Funding Source: the University of Pittsburgh KARAT Catalyst Grant)